approval · primary record
RISANKIZUMAB-RZAA
FDA · BLA · 2026-10-23
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-10-23 |
| Brand | SKYRIZI |
| Sponsor | ABBVIE INC |
| Route | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-29T08:50:42.378Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:RISANKIZUMAB-RZAA:2026-10-23
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Risankizumab-Rzaa · compound